[Medication: 15 years 'EU-directive orphan drugs']. | Bull Cercle Benelux Hist Pharm;(128): 21-6, 2015 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL TCIM Americas

Traditional, Complementary and Integrative Medicine in the Americas VHL

Subject descriptor lookup Advanced Search

[Medication: 15 years 'EU-directive orphan drugs']. / WEESGENEESMIDDELEN: 15 Jaren "EU-directive orphan drugs".

Dooms, Marc.

Bull Cercle Benelux Hist Pharm ; (128): 21-6, 2015 Mar.

Article in Nl | MEDLINE | ID: mdl-26137669

Subject(s)

Economics, Pharmaceutical; Orphan Drug Production; Rare Diseases/drug therapy; Belgium; Humans; Insurance, Health, Reimbursement/economics; Insurance, Health, Reimbursement/standards; National Health Programs; Orphan Drug Production/economics; Orphan Drug Production/standards; Reimbursement Mechanisms/economics; Reimbursement Mechanisms/standards

Search on Google

Database: MEDLINE Main subject: Orphan Drug Production / Economics, Pharmaceutical / Rare Diseases Type of study: Health_economic_evaluation Country/Region as subject: Europa Language: Nl Journal: Bull Cercle Benelux Hist Pharm Year: 2015 Type: Article

Search on Google

Database: MEDLINE Main subject: Orphan Drug Production / Economics, Pharmaceutical / Rare Diseases Type of study: Health_economic_evaluation Country/Region as subject: Europa Language: Nl Journal: Bull Cercle Benelux Hist Pharm Year: 2015 Type: Article